心脏神经衰竭:我们在哪里?
Jose Carlos Pachon1, Enrique Indalecio Pachon2, Tolga Aksu3
1Dante Pazzanese Cardiology Institute, São Paulo Heart Hospital, São Paulo University, São Paulo, Brazil.
Heart rhythm O2
|June 26, 2023
概括
心脏神经移除,一种导管移除技术,在自主功能障碍方面显示出有前途. 需要进一步的研究,以解决知识差距,在广泛临床使用之前,用于诸如血管综合症等疾病.
科学领域:
- 心脏病学 心脏病学
- 自主神经系统的调节规则
背景情况:
- 导管切除技术,称为心脏神经切除,已经成为调节自主功能的战略.
- 观察数据表明,与阴道度增加相关的疾病有潜在的益处,包括血管,功能性心房阻塞和鼻节功能障碍.
研究的目的:
- 审查患者选择,当前的技术,绘制策略和心脏神经衰竭的临床经验.
- 确定与这种新兴治疗方式相关的局限性和知识差距.
主要方法:
- 对有关心脏神经衰竭的现有文献和观察数据的综述.
- 分析技术,绘制策略和临床结果.
主要成果:
- 心脏神经衰竭是一种潜在的治疗方法,用于治疗高阴道症介导的疾病.
- 目前的数据主要是观测数据,突出显示需要进一步调查.
结论:
- 心脏神经衰变治疗对某些患有高血压症相关症状的患者具有前景.
- 对于临床实施,必须解决重大知识差距和必要的下一步措施.
更多相关视频
相关概念视频
01:19Electrophysiology of Normal Cardiac Rhythm
6.6K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
6.6K
01:30Cardiac Action Potential
1.8K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.8K
01:29Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
29
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
29
01:23Cardiopulmonary Resuscitation III: AED Use
42
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
42
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11